PRESS RELEASE: Change of date: 6-month 2010 financial report on August 5, 2010

MediGene AG / Change of date: 6-month 2010 financial report on August 5, 2010 processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement.

Martinsried/Munich, July 23, 2010. Medigene AG (Frankfurt, Prime Standard, MDG,

TecDAX) announces that for organisational reasons the publication of the

6-month 2010 financial report has been rescheduled to Thursday, August 5, 2010

(previously: Friday, August 6, 2010).

An analyst conference call and webcast in English will take place at 10:00 am

CET on Thursday, August 5, 2010. Access to the webcast including synchronized

slides will be possible at the MediGene website at www.medigene.com. A replay

will also be available thereafter.

- ends -

MediGene AG is a publicly listed (Frankfurt, Prime Standard: MDG, TecDAX)

biotechnology company located in Martinsried/Munich, Germany, with subsidiaries

in Oxford, UK and San Diego, USA. MediGene is the first German biotech company

to have drugs on the market which are distributed by partner companies. It has

several drug candidates in clinical development and possesses innovative

platform technologies. MediGene focuses on clinical research and development of

novel drugs with focus on oncology.

Contact MediGene AG

Email: investor@medigene.com

Fax: ++49 - 89 - 85 65 - 2920

Julia Hofmann / Dr. Nadja Wolf, Public Relations, Tel.: ++49 - 89 - 85 65 - 3324

Dr. Georg Dönges, Investor Relations, Tel.: ++49 - 89 - 85 65 - 2946

[HUG#1433783]

--- End of Message ---

MediGene AG

Lochhamer Strasse 11 Martinsried / München Germany

WKN: 502090;ISIN: DE0005020903;

Listed: Freiverkehr in Börse Stuttgart,

Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg,

Freiverkehr in Börse Düsseldorf,

Freiverkehr in Bayerische Börse München,

Freiverkehr in Niedersächsische Börse zu Hannover,

Prime Standard in Frankfurter Wertpapierbörse,

Regulierter Markt in Frankfurter Wertpapierbörse;

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

All reproduction for further distribution is prohibited.

Source: MediGene AG via Thomson Reuters ONE

http://www.medigene.com

(END) Dow Jones Newswires

July 23, 2010 09:00 ET (13:00 GMT)

Quelle: DJ-Newswire